Buy these ASX growth shares this week: experts

Lithium, technology, and sleep treatment shares are where analysts are telling growth investors to put their money…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors looking for ASX growth shares to buy might want to look at the three listed below.

These shares have been named as buys and tipped to climb meaningfully from current levels. Here's what you need to know:

Broker looking at the share price on her laptop with green and red points in the background.

Image source: Getty Images

Pilbara Minerals Ltd (ASX: PLS)

This first ASX growth share to buy could be Pilbara Minerals. It is one of the world's leading lithium miners with a collection of high quality assets that are generating significant free cash flow. So much so, the company recently declared its maiden dividend. And while recent pressure on lithium prices has weighed on sentiment, the team at Morgans believe prices could soon benefit from "demand in the Chinese market [increasing] from March onwards."

Morgans currently has an add rating and $4.70 price target on this lithium miner's shares.

Readytech Holdings Ltd (ASX: RDY)

Another ASX growth share to buy could be Readytech. It is a leading provider of mission-critical software-as-a-service (SaaS) solutions for the education, employment services, workforce management, government and justice sectors. Goldman Sachs is bullish on the company due to its attractive valuation and exposure to government software. It notes that the latter "has been a pocket of strength and resilience" and expects it to help "deliver mid-teens organic growth at an expanding profit margin through the cycle."

Goldman has a buy rating and $4.40 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX growth share to buy could be ResMed. It is a medical device company with a focus on the sleep disorder treatment market. Goldman is also bullish on ResMed and believes it is well-placed for growth in the coming years. In fact, its analysts "currently model an EPS CAGR of +11% (FY23-26E), with potential upside depending on how competitive/regulatory dynamics develop."

Goldman has a buy rating and $38.00 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ReadyTech and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended ReadyTech. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 fantastic ASX shares that could help build long-term wealth

Analysts think these shares are in the buy zone right now.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

2 ASX 200 shares I rate as top buys for growth

These sizeable businesses could scale significantly from here…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

Where to invest $7,000 in ASX shares during April

I’m optimistic that these ASX shares could beat the stock market.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Growth Shares

3 ASX 200 shares that could quietly compound for years

Let's see what sets these shares apart from the crowd.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Growth Shares

3 ASX shares tipped to grow 100% or more in the next 12 months

Here’s how much these exciting stocks could rise in the year ahead.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Analysts think it’s a good time to invest in these names…

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 under-the-radar ASX shares with bags of potential

It could be worth getting better acquainted with these shares.

Read more »

Happy man working on his laptop.
Growth Shares

Brokers rate these 3 top ASX shares as buys in April

Experts are optimistic about what these businesses can achieve.

Read more »